Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company SialoTec GmbH
DescriptionCD22 ligand based targeted therapy
Molecular Target CD22
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationNon-Hodgkin's lymphoma (NHL)
Indication DetailsTreat non-Hodgkin's lymphoma (NHL)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today